Volume: 10 Issue: 3
Year: 2022, Page: 72-77, Doi: https://doi.org/10.47799/pimr.1003.13
Received: Nov. 30, 2022 Accepted: Dec. 12, 2022 Published: Dec. 12, 2022
Introduction: Hypertension is a major risk factor for cardiovascular diseases. Raised homocysteine level is also an important independent risk factor for CVD. This study sought to determine whether there is any relationship between plasma homocysteine and blood pressure levels.
Method: A case control study was conducted among 200 hypertensive cases and 200 normal healthy control groups. Cases were from the Department of medicine and hypertensive clinics at GMC, Baramati and similar controls were selected from patients’ neighborhood. Detailed clinical assessment as well as plasma homocysteine level were assessed and compared in both.
Results: Hypertensive cases had higher mean homocysteine level (21.3 ± 4.6 μmol/L) from controls (13.0 ± 6.0 μmol/L), p<0.001. Homocysteine is positively correlated with both systolic and diastolic blood pressure among both hypertensive patients and healthy controls. In both hypertensive subjects and healthy control, homocysteine level has weak positive correlation with DBP and moderate to strong positive correlation with SBP. The hypertensive cases had very high chance (OR=52.4) of developing hyperhomocysteinemia (>15 μmol/L), p<0.001.
Conclusion: This study showed higher mean plasma homocysteine levels in hypertensive subjects than controls. Serum homocysteine concentrations were positively associated with both systolic and diastolic blood pressure levels in a general adult population.
Keywords: Plasma homocysteine, hypertension, Case control, blood pressure.
Skeete, J & Dipette, D J . 2017. Relationship between homocysteine and hypertension: New data add to the debate. J Clin Hypertens 19:1171–1172.
Boushey, C, Beresford, S, Omenn, G & Motulsky, A . 1995. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274:1049–1057.
Nygard, O, Nordrehaug, J E, Refsum, H, Ueland, P M, Farstad, M & Vollset, S E . 1997. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337:230–236.
Vollset, S E, Refsum, H, Tverdal, A, Nygard, O, Nordrehaug, J E & Tell, G S . 2001. Plasma total homocysteine and cardiovascular and non-cardiovascular mortality: the Hordaland Homocytseine Study. Am J Clin Nutr 74:130–136.
Bots, M L, Launer, L J, Lindemans, J, Hoes, A W, Hofman, A & Witteman, J C . 1999. Homocysteine and short-term risk of myocardial infraction and stroke in the elderly: the Rotterdam Study. Arch Intern Med 159:38–44.
Bostom, A G, Rosenberg, I H, Silbershatz, H, Jacques, P F, Selhub, J, Agostino, D & R B . 1999. Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study. Ann Intern Med 131:352–355.
Vasan, R S, Beiser, A, Agostino, D, Levy, R B, Selhub, D, Jacques, J & P F . 2003. Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infraction. JAMA 289:1251–1257.
Van De Bosch, M A, Bloemenkamp, D G, Mali, W P, Kemmeren, J M, Tanis, B C & Algra, A . 2003. Hyperhomocystenemia and risk for peripheral arterial occlusive disease in young women. J Vasc Surg 38:772–778.
Vyssoulisg, Karpanou E, Kyvelou, S M, Adamopoulos, D, Gialernios, T & Gymnopoulou, E . 2010. Associations between plasma homocysteine levels, aortic stiffness and wave reflection in patients with arterial hypertension, isolated office hypertension and normotensive controls. Journal of Human Hypertension 24:183–189.
Momin, M, Fan, F, Li, J, Qin, X, Jia, J & Qi, L . 2017. Associations of plasma homocysteine levels with peripheral systolic blood pres-sure and noninvasive central systolic blood pressure in a community-based Chinese population. Sci Rep 7(1):6316.
Tao, L X, Yang, K, Wu, J, Mahara, G, Zhang, J & Zhang, J B . 2018. Association between plasma homocysteine and hypertension: Results from a cross-sectional and longitudinal analysis in Beijing's adult population from 2012 to 2017. J Clin Hypertens (Greenwich) 20(11):1624–1632.
Dominguez, L J, Galioto, A & Pineo, A . 2010. Age, homocysteine, and oxidative stress: relation to hypertension and type 2 diabetes mellitus. J Am Coll Nutr 29(1):1–6.
Lu, H, Lu, Z H, Li, P G, Wang, Y Y & Yan, Z Y . 2010. Elevated homocysteine and hypertension in Xinjiang Province. China. Ethn Dis 20(1):7–10.
Sen, U, Mishra, P K, Tyagi, N & Tyagi, S C . 2010. Homocysteine to hydrogen sulfide or hypertension. Cell Biochem Biophys 57(2-3):49–58.
Tao, L X, Wu, Yang K, Mahara, L, Zhang, G, Zhang, J & J B . 2018. Association between plasma homocysteine and hypertension:Results from a cross-sectional and longitudinal analysis in Beijing’s adult population from 2012 to 2017. J Clin Hypertens 20:1624–1632.
Borges, M C, Hartwigfp, , Oliveira, I O & Horta, B L . 2016. Is there a causal role for homocysteine concentration in blood pressure? A Mendelian randomization study. Am J Clin Nutr 103:39–49.
Onyemelukwe, O U & Maiha, B B . 2011. Relationship between plasma homocysteine and blood pressure in hypertensive Northern-Nigerians. African Health Sciences 20(1):324–337.
Ajuluchukwu, J, Oluwatowoju, I O, Adebayo, K & Onakoya, A . 2011. Plasma homocysteine in diverse cardiovascular diseases in urban Africans. World Life Science and MedicalResearch 1(6):126–131.
Balakumar, P, Singh, P A, Subrahmanya, S G & Singh, M . 2007. Hyperhomocysteinemia and cardiovascular disorders: is there a correlation? Trends in Medical Research 2:160–166.
Junedi M, Junaidi A, Yadagir R. Association of high blood pressure with raised homocysteine level among urban population- A case control study. Perspectives in Medical Research. 2022;10(3):72- 77 DOI: 10.47799/pimr.1003.13